Earlier this week, an FDA advisory panel recommended expanding the indication for Abbott Laboratories carotid stent system to include use in lower-risk carotid endarterectomy patients. This decision was primarily based on results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).
FDA Panel Recommends Expansion of CAS Indications
Recently, Thomson Reuters announced the results of their annual, quantitative study determining the nation's 50 Top Cardiovascular Hospitals. To identify top hospitals, Thomson Reuters assesses clinical outcomes and process measures, 30-day readmissions and mortality, length of stay, and cost per case for patients with heart failure and coronary atherosclerosis.
This year, two hospitals from the Bon Secours Health System—St. Mary's Hospital in Richmond, Va., and Memorial Regional Medical in Mechanicsville, Va.—were recognized for excellence in the categories of "Teaching hospitals without a cardiovascular residency program" and "Community hospitals," respectively.
Joining Forces to Achieve Excellence: A Q&A with Bon Secours
Circulation recently featured the American Heart Association's 20-year forecasts for the prevalence of cardiovascular disease and associated costs, as described in the table below.
Prevalence, Cost of CVD Expected to Grow Substantially